Intellia Therapeutics Inc. (NTLA) declined -5.04% or -0.77 to $14.5. It is near 374529 shares traded, which is 53.61% compare to the average total volume 698571. The market cap of NTLA is $629.58 million. The year to date change is -34.05%. The 52 week price range is from $14.3 to $35.99. Price of NTLA have changed -7.40% during last week. It have changed -8.56% over last month, -48.84% over last 3 months, -47.25% over last 6 months and -17.64% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 19.16. It is 32.14% above current price. The 200-day Moving Averages for NTLA is 24.74. It is 70.62% above current price. The 52-week High is 35.99. It is 148.21% from the current price. The 52-week Low is 14.3. It is -1.38% from current price.
There are some statistics of NTLA. It is has market cap $629.58 million. The share outstanding is 43.42 million. The average volume is 698571. The percent of top 15 Institution holding is 100.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -41.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -31.64%.